van Karnebeek CDM, O’Donnell-Luria A, Baynam G, et al. Leaving no patient behind! Expert recommendation in the use of innovative technologies for diagnosing rare diseases. Orphanet journal of rare diseases. 2024;19(1):357. doi:10.1186/s13023-024-03361-0
Chong JX, Berger SI, Baxter S, et al. Considerations for reporting variants in novel candidate genes identified during clinical genomic testing. Genetics in medicine : official journal of the American College of Medical Genetics. 2024;26(10):101199. doi:10.1016/j.gim.2024.101199
Stenton SL, O’Leary MC, Lemire G, et al. Critical assessment of variant prioritization methods for rare disease diagnosis within the rare genomes project. Human genomics. 2024;18(1):44. doi:10.1186/s40246-024-00604-w
Seaby EG, Leggatt G, Cheng G, et al. A gene pathogenicity tool "GenePy" identifies missed biallelic diagnoses in the 100,000 Genomes Project. Genetics in medicine : official journal of the American College of Medical Genetics. 2024;26(4):101073. doi:10.1016/j.gim.2024.101073
Pignolo RJ, Mukaddam MA, Baujat G, et al. Study methodology and insights from the palovarotene clinical development program in fibrodysplasia ossificans progressiva. BMC medical research methodology. 2023;23(1):269. doi:10.1186/s12874-023-02080-7
Hills S, Li Q, Madden JA, et al. High number of candidate gene variants are identified as disease-causing in a period of 4 years. American journal of medical genetics. Part A. 2023. doi:10.1002/ajmg.a.63509
Seaby EG, Thomas S, Hunt D, et al. A Panel-Agnostic Strategy ’HiPPo’ Improves Diagnostic Efficiency in the UK Genomic Medicine Service. Healthcare (Basel, Switzerland). 2023;11(24). doi:10.3390/healthcare11243179
Stenton SL, O’Leary M, Lemire G, et al. Critical assessment of variant prioritization methods for rare disease diagnosis within the Rare Genomes Project. medRxiv : the preprint server for health sciences. 2023. doi:10.1101/2023.08.02.23293212
Martin-Geary AC, Blakes AJM, Dawes R, et al. Systematic identification of disease-causing promoter and untranslated region variants in 8,040 undiagnosed individuals with rare disease. medRxiv : the preprint server for health sciences. 2023. doi:10.1101/2023.09.12.23295416
Serrano JG, O’Leary M, VanNoy GE, et al. Advancing Understanding of Inequities in Rare Disease Genomics. Clinical therapeutics. 2023. doi:10.1016/j.clinthera.2023.06.010